Label updates in 2023 through 2025 added disclosures for ileus, intestinal obstruction, and other complications
doi: 10.1053/j.gastro.2008.10.080 54
Both are worth knowing
It was then followed by liraglutide 1.8 mg (Victoza, Novo Nordisk) in 2009, dulaglutide 1.5 mg (Trulicity, Eli Lilly) in 2014, and liraglutide 3.0 mg (Saxenda, Novo Nordisk) in 2014
It maps pathway-level variants such as GLP1R, FTO, MC4R, and TCF7L2, giving you baseline metabolic context to weigh alongside cost when discussing options with a provider
Key Applications Across Industries Pharmaceutical companies put this high-quality ingredient into medicines that are meant to protect the liver, especially for people who are exposed to hepatotoxic agents or have chronic oxidative stress